RE: What do we think, full sale or jv?26 Apr 2021 13:32
Who knows? (Well, Dmitri does I suppose :-)
If it is an asset sale, a 50p-70p special dividend now doesn't sound like as much to me as it would have done a year ago, and I would hope for a little more depending on the structure of the transaction. That amount implies selling MT/WK for about £3bn (assuming they retain 30% for paying UBS and keeping a good chunk towards financing the JV on the Rosgeo assets). I'd be just about happy with that, depending on the level of forward dilution, the cost of participating in any rights issue and the likely scale of future JV dividends. If we're talking 20p/yr for the next 20 years after dilution which costs us 10p of the 70p we've just received, then all good. If it's a 5p dividend that costs 40p, not so much.
Given (a) where we're at now, (b) the length of time this has taken, with the presumed number of different bidders, and (c) the outlook for PGM prices, where MT alone will potentially be worth $150bn by the end of the decade (and possibly two or three times that if we get anywhere beyond the 15m oz) then £3bn just sounds a bit low. Why would we not just mine ourselves? And why would another bidder not have ponied up, say, £3.5bn? Then, if they did, why would another not have been happy to pay £4bn for MT? Where does it end?
Of course, a real sweetener would be sale of MT, special dividend, and EUA moving forward with the Rosgeo JV while also retaining, say, 10% of all future Monchetundra revenues. That would be absolutely killer. But can it be achieved? Would seem a nice trade-off potentially for taking in the region of £3bn now.
Overall, I'm still expecting/hoping for a full sale personally. Somewhere between £1.50 and £2.70 would, I think, see everyone leaving the table thinking they've won. I can't see it being much less than that now; but wouldn't be surprised if Rowka was right and it's a little higher. I don't buy the truly silly money prices that take us beyond about $10bn overall though. I just don't see how any major firm could take on that much risk (even on $10bn the financing would cost the best part of half a billion dollars/yr in interest) regardless of how confident they might be in their future PGM price projections.